{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:23:26Z","timestamp":1793237006756,"version":"4.5.0"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T00:00:00Z","timestamp":1585526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11886-020-01279-0","type":"journal-article","created":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T05:04:10Z","timestamp":1585544650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["High-Sensitivity Troponins in Cardiovascular Disease"],"prefix":"10.1007","volume":"22","author":[{"given":"Michael C.","family":"Kontos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy S.","family":"Turlington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,30]]},"reference":[{"key":"1279_CR1","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","volume":"36","author":"The Joint European Society of Cardiology\/American College of Cardiology Committee","year":"2000","unstructured":"The Joint European Society of Cardiology\/American College of Cardiology Committee. Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959\u201369.","journal-title":"J Am Coll Cardiol"},{"issue":"72","key":"1279_CR2","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","volume":"30","author":"K Thygesen","year":"2018","unstructured":"\u2022\u2022 Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;30(72):2231\u201364 Updated recommendations for classification of myocardial infarction. A must read for background for classification of troponin elevations.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR3","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1373\/clinchem.2018.298059","volume":"65","author":"A Anand","year":"2019","unstructured":"Anand A, Shah ASV, Beshiri A, Jaffe AS, Mills NL. Global adoption of high-sensitivity cardiac troponins and the universal definition of myocardial infarction. Clin Chem. 2019;65:484\u20139.","journal-title":"Clin Chem"},{"key":"1279_CR4","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1373\/clinchem.2017.277186","volume":"64","author":"AHB Wu","year":"2018","unstructured":"Wu AHB, Christenson RH, Greene DN, Jaffe AS, Kavsak PA, Ordonez-Llanos J, et al. Clinical laboratory practice recommendations for the use of cardiac troponin in acute coronary syndrome: expert opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine. Clin Chem. 2018;64:645\u201355.","journal-title":"Clin Chem"},{"key":"1279_CR5","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1373\/clinchem.2011.171082","volume":"58","author":"PO Collinson","year":"2012","unstructured":"\u2022 Collinson PO, Heung YM, Gaze D, Boa F, Senior R, Christenson R, et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin Chem. 2012;58:219\u201325 Describes how the 99th percentile is variable depending on baseline patient characteristics.","journal-title":"Clin Chem"},{"key":"1279_CR6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.113.004420","volume":"129","author":"L Wallentin","year":"2014","unstructured":"\u2022 Wallentin L, Lindholm D, Siegbahn A, Wernroth L, Becker RC, Cannon CP, et al. Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibition and Patient Outcomes (PLATO) trial. Circulation. 2014;129:293\u2013303 Differential response to type category based on high sensitivity troponin results.","journal-title":"Circulation"},{"issue":"127","key":"1279_CR7","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1161\/CIRCULATIONAHA.113.001258","volume":"18","author":"E Braunwald","year":"2013","unstructured":"Braunwald E, Morrow DA. Unstable angina: is it time for a requiem? Circulation. 2013;18(127):2452\u20137.","journal-title":"Circulation"},{"key":"1279_CR8","doi-asserted-by":"crossref","unstructured":"Puelacher C, Gugala M, Adamson PD, Shah A, Chapman AR, Anand A, et al. Incidence and outcomes of unstable angina compared with non-ST-elevation myocardial infarction. Heart. 2019; Apr 24E published.","DOI":"10.1093\/eurheartj\/ehz748.0450"},{"key":"1279_CR9","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.amjmed.2015.01.044","volume":"128","author":"M D\u2019Souza","year":"2015","unstructured":"D\u2019Souza M, Sarkisian L, Saaby L, Poulsen TS, Gerke O, Larsen TB, et al. Diagnosis of unstable angina pectoris has declined markedly with the advent of more sensitive troponin assays. Am J Med. 2015;128:852\u201360.","journal-title":"Am J Med"},{"key":"1279_CR10","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/S0002-8703(03)00245-X","volume":"146","author":"MC Kontos","year":"2003","unstructured":"Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J. 2003;146:446\u201352.","journal-title":"Am Heart J"},{"key":"1279_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ahj.2015.11.010","volume":"173","author":"G Lee","year":"2016","unstructured":"Lee G, Twerenbold R, Tanglay Y, Reichlin T, Honegger U, Wagener M, et al. Clinical benefit of high-sensitivity cardiac troponin I in the detection of exercise-induced myocardial ischemia. Am Heart J. 2016;173:8\u201317.","journal-title":"Am Heart J"},{"key":"1279_CR12","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1016\/j.jacc.2010.11.066","volume":"57","author":"AT Turer","year":"2011","unstructured":"Turer AT, Addo TA, Martin JL, Sabatine MS, Lewis GD, Gerszten RE, et al. Myocardial ischemia induced by rapid atrial pacing causes troponin T release detectable by a highly sensitive assay: insights from a coronary sinus sampling study. J Am Coll Cardiol. 2011;57:2398\u2013405.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.annemergmed.2015.11.013","volume":"68","author":"C Mueller","year":"2016","unstructured":"\u2022 Mueller C, Giannitsis E, Christ M, Ord\u00f3\u00f1ez-Llanos J, de Filippi C, McCord J, et al. TRAPID-AMI Investigators. Multicenter evaluation of a 0-hour\/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med. 2016;68:76\u201387 First large study to describe the 1 hour rule out process.","journal-title":"Ann Emerg Med"},{"key":"1279_CR14","doi-asserted-by":"publisher","first-page":"e003101","DOI":"10.1161\/CIRCOUTCOMES.116.003101","volume":"10","author":"J McCord","year":"2017","unstructured":"McCord J, Cabrera R, Lindahl B, Giannitsis E, Evans K, Nowak R, et al. Prognostic utility of a modified HEART score in chest pain patients in the emergency department. Circ Cardiovasc Qual Outcomes. 2017;10:e003101.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"1279_CR15","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jacc.2019.05.058","volume":"74","author":"Y Sandoval","year":"2019","unstructured":"Sandoval Y, Nowak R, de Filippi CR, Christenson RH, Peacock WF, McCord J, et al. Myocardial infarction risk stratification with a single measurement of high-sensitivity troponin I. J Am Coll Cardiol. 2019;74:271\u201382.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.annemergmed.2018.11.039","volume":"73","author":"L Ljung","year":"2019","unstructured":"Ljung L, Lindahl B, Eggers KM, Frick M, Linder R, L\u00f6fmark HB, et al. A rule-out strategy based on high-sensitivity troponin and HEART score reduces hospital admissions. Ann Emerg Med. 2019;73:491\u20139.","journal-title":"Ann Emerg Med"},{"key":"1279_CR17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.annemergmed.2015.07.006","volume":"66","author":"EW Carlton","year":"2015","unstructured":"Carlton EW, Khattab A, Greaves K. Identifying patients suitable for discharge after a single-presentation high-sensitivity troponin result: a comparison of five established risk scores and two high-sensitivity assays. Ann Emerg Med. 2015;66:635\u201345.","journal-title":"Ann Emerg Med"},{"key":"1279_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1373\/clinchem.2018.294124","volume":"65","author":"J Boeddinghaus","year":"2019","unstructured":"Boeddinghaus J, Nestelberger T, Badertscher P, Twerenbold R, Fitze B, Wussler D, et al. Predicting acute myocardial infarction with a single blood draw. Clin Chem. 2019;65:437\u201350.","journal-title":"Clin Chem"},{"key":"1279_CR19","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/S0140-6736(15)00391-8","volume":"386","author":"AS Shah","year":"2015","unstructured":"\u2022 Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015;386:2481\u20138 First large study using high sensitivity troponin I for MI rule out. Defines the role of single marker assessment, both advantages and limitations.","journal-title":"Lancet"},{"key":"1279_CR20","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.119.042866","volume":"140","author":"A Bularga","year":"2019","unstructured":"\u2022 Bularga A, Lee KK, Stewart S, Ferry AV, Chapman AR, Marshall L, et al. High-sensitivity troponin and the application of risk stratification thresholds in patients with suspected acute coronary syndrome. Circulation. 2019;140:1557\u201368 Demonstrates in a large number of patients that troponin values <99th percentile are at substantial risk for long-term events.","journal-title":"Circulation"},{"key":"1279_CR21","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.119.042891","volume":"140","author":"DP Chew","year":"2019","unstructured":"Chew DP, Lambrakis K, Blyth A, Seshadri A, Edmonds MJR, Briffa T, et al. A randomized trial of a 1-hour troponin t protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible Acute Coronary Syndrome in the Emergency Department With High-Sensitivity Troponin T Study (RAPID-TnT). Circulation. 2019;140:1543\u201356.","journal-title":"Circulation."},{"key":"1279_CR22","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.jacc.2018.12.013","volume":"73","author":"B Morawiec","year":"2019","unstructured":"Morawiec B, Boeddinghaus J, Wussler D, Badertscher P, Koechlin L, Metry F, et al. Modified HEART score and high-sensitivity cardiac troponin in patients with suspected acute myocardial infarction. J Am Coll Cardiol. 2019;73:873\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR23","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1161\/CIRCULATIONAHA.118.036426","volume":"138","author":"AR Chapman","year":"2018","unstructured":"Chapman AR, Hesse K, Andrews J, Ken Lee K, Anand A, Shah ASV, et al. High-sensitivity cardiac troponin i and clinical risk scores in patients with suspected acute coronary syndrome. Circulation. 2018;138:1654\u201365.","journal-title":"Circulation."},{"key":"1279_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ijcard.2016.01.112","volume":"207","author":"T Nestelberger","year":"2016","unstructured":"\u2022 Nestelberger T, Wildi K, Boeddinghaus J, Twerenbold R, Reichlin T, Gim\u00e9nez MR, et al. Characterization of the observe zone of the ESC 2015 high-sensitivity cardiac troponin 0h\/1h-algorithm for the early diagnosis of acute myocardial infarction. Int J Cardiol. 2016;207:238\u201345 Describes outcomes in intermediate\/observation patients.","journal-title":"Int J Cardiol"},{"key":"1279_CR25","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1093\/eurheartj\/ehw232","volume":"37","author":"R Twerenbold","year":"2016","unstructured":"Twerenbold R, Jaeger C, Rubini Gimenez M, Wildi K, Reichlin T, Nestelberger T, et al. Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. Eur Heart J. 2016;37:3324\u201332.","journal-title":"Eur Heart J"},{"key":"1279_CR26","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1161\/CIRCULATIONAHA.118.033861","volume":"138","author":"R Vigen","year":"2018","unstructured":"\u2022 Vigen R, Kutscher P, Fernandez F, Yu A, Bertulfo B, Hashim IA, et al. Evaluation of a novel rule-out myocardial infarction protocol incorporating high-sensitivity troponin t in a US hospital. Circulation. 2018;138:2061\u20133 First description of high sensitive troponins used in the United States for MI rule out. Unique feature of this study is defining higher troponins has abnormal rather than rule ends.","journal-title":"Circulation"},{"key":"1279_CR27","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jacc.2019.05.046","volume":"74","author":"R Twerenbold","year":"2019","unstructured":"Twerenbold R, Costabel JP, Nestelberger T, Campos R, Wussler D, Arbucci R, et al. Outcome of applying the ESC 0\/1-hour algorithm in patients with suspected myocardial infarction. Mueller C. J Am Coll Cardiol. 2019;74:483\u201394.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR28","doi-asserted-by":"crossref","unstructured":"Stoyanov KM, Hund H, Biener M, Gandowitz J, Riedle C, L\u00f6hr J, et al. RAPID-CPU: a prospective study on implementation of the ESC 0\/1-hour algorithm and safety of discharge after rule-out of myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019;12 in press.","DOI":"10.1177\/2048872619861911"},{"key":"1279_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.jacc.2019.06.014","volume":"74","author":"PV Caposino","year":"2019","unstructured":"Caposino PV, Kondratovich MV. Considerations for single-measurement risk-stratification strategies for myocardial infarction using cardiac troponin assays. J Am Coll Cardiol. 2019;74:283\u20134.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR30","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1373\/clinchem.2016.254730","volume":"63","author":"LA Cullen","year":"2017","unstructured":"\u2022 Cullen LA, Mills NL, Mahler S, Body R. Early rule-out and rule-in strategies for myocardial infarction. Clin Chem. 2017;63:129\u201339 Good description of the advantages and limitations of \u201crule in\u201d and \u201crule out\u201d strategies using high sensitivity troponins.","journal-title":"Clin Chem"},{"key":"1279_CR31","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1056\/NEJMoa1803377","volume":"380","author":"JT Neumann","year":"2019","unstructured":"Neumann JT, Twerenbold R, Ojeda F, S\u00f6rensen NA, Chapman AR, ASV S, et al. Application of high-sensitivity troponin in suspected myocardial infarction. N Engl J Med. 2019;380:2529\u201340.","journal-title":"N Engl J Med"},{"key":"1279_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.amjmed.2014.10.056","volume":"128","author":"AS Shah","year":"2015","unstructured":"Shah AS, McAllister DA, Mills R, Lee KK, Churchhouse AM, Fleming KM, et al. Sensitive troponin assay and the classification of myocardial infarction. Am J Med. 2015;128:493\u2013501.","journal-title":"Am J Med"},{"key":"1279_CR33","doi-asserted-by":"publisher","first-page":"446.e5","DOI":"10.1016\/j.amjmed.2015.11.006","volume":"129","author":"L Sarkisian","year":"2016","unstructured":"Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med. 2016;129:446.e5\u2013446.","journal-title":"Am J Med"},{"key":"1279_CR34","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/heartjnl-2016-310243","volume":"103","author":"G Cediel","year":"2017","unstructured":"Cediel G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, Boqu\u00e9 C, Bardaj\u00ed A. Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury. Heart. 2017;103:616\u201322.","journal-title":"Heart."},{"key":"1279_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.amjmed.2013.12.020","volume":"127","author":"L Saaby","year":"2014","unstructured":"Saaby L, Poulsen TS, Diederichsen AC, Hosbond S, Larsen TB, Schmidt H, et al. Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort. Am J Med. 2014;127:295\u2013302.","journal-title":"Am J Med"},{"key":"1279_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","volume":"137","author":"AR Chapman","year":"2018","unstructured":"Chapman AR, Shah ASV, Lee KK, Anand A, Francis O, Adamson P, et al. Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury. Circulation. 2018;137:1236\u2013124.","journal-title":"Circulation."},{"key":"1279_CR37","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1373\/clinchem.2011.163758","volume":"57","author":"JA de Lemos","year":"2011","unstructured":"de Lemos JA, Morrow DA, de Filippi CR. Highly sensitive troponin assays and the cardiology community: a love\/hate relationship? Clin Chem. 2011;57:826\u20139.","journal-title":"Clin Chem"},{"key":"1279_CR38","doi-asserted-by":"publisher","first-page":"j4788","DOI":"10.1136\/bmj.j4788","volume":"359","author":"ASV Shah","year":"2017","unstructured":"\u2022 Shah ASV, Sandoval Y, Noaman A, Sexter A, Vaswani A, Smith SW, et al. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ. 2017;359:j4788 Study demonstrating different threshold for troponin sampling in the UK and United States.","journal-title":"BMJ"},{"issue":"56","key":"1279_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.jacc.2010.06.016","volume":"28","author":"RD Kociol","year":"2010","unstructured":"\u2022\u2022 Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O\u2019Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;28(56):1071\u20138 Good summary of the association of troponin and heart failure.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR40","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jchf.2017.11.003","volume":"6","author":"JDW Evans","year":"2018","unstructured":"Evans JDW, Dobbin SJH, Pettit SJ, Di Angelantonio E, Willeit P. High-sensitivity cardiac troponin and new-onset heart failure: a systematic review and meta-analysis of 67,063 patients with 4,165 incident heart failure events. JACC Heart Fail. 2018;6:187\u201397.","journal-title":"JACC Heart Fail"},{"key":"1279_CR41","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.111.044149","volume":"125","author":"S Masson","year":"2012","unstructured":"\u2022 Masson S, Anand I, Favero C, Barlera S, Vago T, Bertocchi F, et al. Serial measurement of cardiac troponin T using a highly sensitive assay in patients with chronic heart failure: data from 2 large randomized clinical trials. Circulation. 2012;125:280\u20138 First study to demonstrate that troponin is a dynamic process that changes over time that has prognostic significance.","journal-title":"Circulation"},{"key":"1279_CR42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/CIRCHEARTFAILURE.114.001427","volume":"7","author":"PS Jhund","year":"2014","unstructured":"Jhund PS, Claggett BL, Voors AA, Zile MR, Packer M, Pieske BM, et al. Elevation in high-sensitivity troponin T in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696. Circ Heart Fail. 2014;7:953\u20139.","journal-title":"Circ Heart Fail"},{"key":"1279_CR43","doi-asserted-by":"publisher","first-page":"3345","DOI":"10.1093\/eurheartj\/ehz240","volume":"40","author":"DA Morrow","year":"2019","unstructured":"Morrow DA, Velazquez EJ, DeVore AD, Prescott MF, Duffy CI, Gurmu Y, et al. Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial. Eur Heart J. 2019;40:3345\u201352.","journal-title":"Eur Heart J"},{"key":"1279_CR44","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.pcad.2019.02.005","volume":"62","author":"KM Aakre","year":"2019","unstructured":"Aakre KM, Omland T. Physical activity, exercise and cardiac troponins: clinical implications. Prog Cardiovasc Dis. 2019;62:108\u201315.","journal-title":"Prog Cardiovasc Dis"},{"key":"1279_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jacc.2010.03.037","volume":"56","author":"R Shave","year":"2010","unstructured":"\u2022 Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G, et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol. 2010;56:169\u201376 Good summary of the association with troponin and exercise.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR46","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/CIRCULATIONAHA.118.034655","volume":"139","author":"B Lara","year":"2019","unstructured":"Lara B, Salinero JJ, Gallo-Salazar C, Areces F, Ruiz-Vicente D, Martinez M, et al. Elevation of cardiac troponins after endurance running competitions. Circulation. 2019;139:709\u201311.","journal-title":"Circulation."},{"key":"1279_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1161\/CIRCULATIONAHA.119.041627","volume":"140","author":"VL Aengevaeren","year":"2019","unstructured":"Aengevaeren VL, Hopman MTE, Thompson PD, Bakker EA, George KP, Thijssen DHJ, et al. Exercise-induced cardiac troponin I increase and incident mortality and cardiovascular events. Circulation. 2019;140:804\u201314.","journal-title":"Circulation."},{"key":"1279_CR48","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.106.647461","volume":"114","author":"TG Neilan","year":"2006","unstructured":"Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS, et al. Myocardial injury and ventricular dysfunction related to training levels among nonelite participants in the Boston marathon. Circulation. 2006;114:2325\u201333.","journal-title":"Circulation."},{"key":"1279_CR49","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1177\/2048872617748553","volume":"7","author":"J Mair","year":"2018","unstructured":"Mair J, Lindahl B, Hammarsten O, M\u00fcller C, Giannitsis E, Huber K, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7:553\u201360.","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1279_CR50","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.jacc.2019.02.018","volume":"73","author":"Y Sandoval","year":"2019","unstructured":"\u2022 Sandoval Y, Jaffe AS. Type 2 myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2019;73:1846\u201360 Comprehensive review of type 2 myocardial infarction.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR51","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/heartjnl-2017-312409","volume":"104","author":"A Gard","year":"2018","unstructured":"\u2022 Gard A, Lindahl B, Batra G, Hadziosmanovic N, Hjort M, Szummer KE, et al. Interphysician agreement on subclassification of myocardial infarction. Heart. 2018;104:1284\u201391 Good study illustrating the difficulties in classifying patients is having type 2 MI or myocardial infarction.","journal-title":"Heart"},{"key":"1279_CR52","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jacc.2018.12.046","volume":"73","author":"JL Januzzi Jr","year":"2019","unstructured":"\u2022\u2022 Januzzi JL Jr, Mahler SA, Christenson RH, Rymer J, Newby LK, Body R, et al. Recommendations for institutions transitioning to high-sensitivity troponin testing: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019;73:1059\u201377 Important guidelines for US hospitals as the change from contemporary to high sensitivity troponin assays.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR53","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/jamacardio.2019.0716","volume":"4","author":"C McCarthy","year":"2019","unstructured":"\u2022\u2022 McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O\u2019Connor M, Olshan DS, et al. Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs. JAMA Cardiol. 2019;4:460\u20134 Important study pointing out the implications of identifying a patient is having.","journal-title":"JAMA Cardiol"},{"key":"1279_CR54","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.amjmed.2019.02.037","volume":"132","author":"CP McCarthy","year":"2019","unstructured":"McCarthy CP. Type 2 myocardial infarction and value-based programs: cutting the supply in the absence of demand. Am J Med. 2019;132:1117\u20138.","journal-title":"Am J Med"},{"key":"1279_CR55","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jacc.2018.06.055","volume":"72","author":"CP McCarthy","year":"2018","unstructured":"McCarthy CP, Vaduganathan M, Singh A, Song Z, Blankstein R, Gaggin HK, et al. Type 2 myocardial infarction and the hospital readmission reduction program. J Am Coll Cardiol. 2018;72:1166\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR56","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.jcin.2019.07.014","volume":"12","author":"HM Garcia-Garcia","year":"2019","unstructured":"Garcia-Garcia HM, McFadden EP, von Birgelen C, Rademaker-Havinga T, Spitzer E, Kleiman NS, et al. Impact of periprocedural myocardial biomarker elevation on mortality following elective percutaneous coronary intervention. JACC Cardiovasc Interv. 2019;12:1954\u201362.","journal-title":"JACC Cardiovasc Interv"},{"issue":"6","key":"1279_CR57","doi-asserted-by":"publisher","first-page":"e003202","DOI":"10.1161\/CIRCINTERVENTIONS.115.003202","volume":"9","author":"T Zanchin","year":"2016","unstructured":"Zanchin T, R\u00e4ber L, Koskinas KC, Piccolo R, J\u00fcni P, Pilgrim T, et al. Preprocedural high-sensitivity cardiac troponin T and clinical outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention. Circ Cardiovasc Interv. 2016;9(6):e003202.","journal-title":"Circ Cardiovasc Interv"},{"key":"1279_CR58","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1016\/j.jacc.2013.08.720","volume":"62","author":"ID Moussa","year":"2013","unstructured":"Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62:1563\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR59","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/clc.21980","volume":"35","author":"CT Chin","year":"2012","unstructured":"Chin CT, Wang TY, Li S, Wiviott SD, de Lemos JA, Kontos MC, et al. Comparison of the prognostic value of peak creatine kinase-MB and troponin levels among patients with acute myocardial infarction: a report from the Acute Coronary Treatment and Intervention Outcomes Network Registry-get with the guidelines. Clin Cardiol. 2012;35:424\u20139.","journal-title":"Clin Cardiol"},{"issue":"39","key":"1279_CR60","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","volume":"1","author":"M Zeitouni","year":"2018","unstructured":"Zeitouni M, Silvain J, Guedeney P, Kerneis M, Yan Y, Overtchouk P, et al. Periprocedural myocardial infarction and injury in elective coronary stenting. Eur Heart J. 2018;1(39):1100\u20139.","journal-title":"Eur Heart J"},{"key":"1279_CR61","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","volume":"126","author":"K Thygesen","year":"2012","unstructured":"Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. Circulation. 2012;126:2020\u201335.","journal-title":"Circulation"},{"key":"1279_CR62","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jcin.2018.02.006","volume":"11","author":"P Tricoci","year":"2018","unstructured":"\u2022 Tricoci P, Newby LK, Clare RM, Leonardi S, Gibson CM, Giugliano RP, et al. Prognostic and practical validation of current definitions of myocardial infarction associated with percutaneous coronary intervention. JACC Cardiovasc Interv. 2018;11:856\u201364 Indicates that if detection of troponin after PCI is tied to ischemic events, it has the same prognostic value as CK-MB.","journal-title":"JACC Cardiovasc Interv"},{"key":"1279_CR63","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Devereaux PJ, Szczeklik W. Myocardial injury after non-cardiac surgery: diagnosis and management. Eur Heart J. 2019; Good summary of postsurgical troponin elevations.","DOI":"10.1093\/eurheartj\/ehz301"},{"key":"1279_CR64","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1001\/jama.2017.4360","volume":"317","author":"PJ Devereaux","year":"2017","unstructured":"\u2022 Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317:1642\u201351 Demonstrates that troponin elevations after noncardiac surgery are not benign.","journal-title":"JAMA"},{"key":"1279_CR65","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1373\/clinchem.2016.254748","volume":"63","author":"CR de Filippi","year":"2017","unstructured":"de Filippi CR, Herzog CA. Interpreting cardiac biomarkers in the setting of chronic kidney disease. Clin Chem. 2017;63:59\u201365.","journal-title":"Clin Chem"},{"key":"1279_CR66","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.117.030320","volume":"137","author":"E Miller-Hodges","year":"2018","unstructured":"Miller-Hodges E, Anand A, Shah ASV, Chapman AR, Gallacher P, Lee KK, et al. High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation. 2018;137:425\u201335.","journal-title":"Circulation."},{"key":"1279_CR67","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1001\/jama.2010.1708","volume":"304","author":"CR de Filippi","year":"2010","unstructured":"\u2022\u2022 de Filippi CR, de Lemos JA, Christenson RH, Gottdiener JS, Kop WJ, Zhan M, et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA. 2010;304:2494\u2013502 Demonstrates that non elevated high sensitivity troponin in asymptomatic adults is not static but dynamic, and that these changes over time has prognostic value.","journal-title":"JAMA"},{"key":"1279_CR68","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/eurheartj\/ehw172","volume":"37","author":"S Blankenberg","year":"2016","unstructured":"Blankenberg S, Salomaa V, Makarova N, Ojeda F, Wild P, Lackner KJ, et al. Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium. Eur Heart J. 2016;37:2428\u201337.","journal-title":"Eur Heart J"},{"key":"1279_CR69","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.118.038772","volume":"139","author":"X Jia","year":"2019","unstructured":"Jia X, Sun W, Hoogeveen RC, Nambi V, Matsushita K, Folsom AR, et al. High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study. Circulation. 2019;139:2642\u201353.","journal-title":"Circulation."},{"key":"1279_CR70","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1161\/CIRCULATIONAHA.118.038529","volume":"139","author":"P Welsh","year":"2019","unstructured":"Welsh P, Preiss D, Hayward C, Shah ASV, McAllister D, Briggs A, et al. Cardiac troponin T and troponin I in the general population. Circulation. 2019;139:2754\u201364.","journal-title":"Circulation."},{"key":"1279_CR71","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1373\/clinchem.2018.292086","volume":"64","author":"P Welsh","year":"2018","unstructured":"Welsh P, Preiss D, Shah ASV, McAllister D, Briggs A, Boachie C, et al. Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clin Chem. 2018;64:1607\u201316.","journal-title":"Clin Chem"},{"key":"1279_CR72","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/heartjnl-2013-304957","volume":"100","author":"A Dispenzieri","year":"2014","unstructured":"Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK, et al. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart. 2014;100:383\u20138.","journal-title":"Heart."},{"key":"1279_CR73","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","volume":"5","author":"H Sawaya","year":"2012","unstructured":"Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, et al. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging. 2012;5:596\u2013603.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1279_CR74","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejca.2018.02.005","volume":"94","author":"D Cardinale","year":"2018","unstructured":"Cardinale D, Ciceri F, Latini R, Franzosi MG, Sandri MT, Civelli M, et al. Anthracycline-induced cardiotoxicity: a multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial. Eur J Cancer. 2018;94:126\u201337.","journal-title":"Eur J Cancer"},{"key":"1279_CR75","doi-asserted-by":"crossref","unstructured":"Poklepovic A, Qu Y, Dickinson M, Kontos MC, Kmieciak M, Schultz E, et al. Randomized study of doxorubicin-based chemotherapy regimens, with and without sildenafil, with analysis of intermediate cardiac markers. Cardiooncology. 2018;4.","DOI":"10.1186\/s40959-018-0033-2"},{"key":"1279_CR76","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1093\/eurheartj\/ehu189","volume":"35","author":"CW Chin","year":"2014","unstructured":"Chin CW, Shah AS, McAllister DA, Joanna Cowell S, Alam S, Langrish JP, et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J. 2014;35:2312\u201321.","journal-title":"Eur Heart J"},{"key":"1279_CR77","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1161\/CIRCULATIONAHA.119.043337","volume":"140","author":"A Pandey","year":"2019","unstructured":"Pandey A, Patel KV, Vongpatanasin W, Ayers C, Berry JD, Mentz RJ, et al. Incorporation of biomarkers into risk assessment for allocation of antihypertensive medication according to the 2017 ACC\/AHA high blood pressure guideline: a pooled cohort analysis. Circulation. 2019;140:2076\u201388.","journal-title":"Circulation"},{"key":"1279_CR78","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1093\/eurheartj\/ehu188","volume":"35","author":"M Rubini Gimenez","year":"2014","unstructured":"Rubini Gimenez M, Twerenbold R, Reichlin T, Wildi K, Haaf P, Schaefer M, et al. Direct comparison of high-sensitivity-cardiac troponin I vs. T for the early diagnosis of acute myocardial infarction. Eur Heart J. 2014;35:2303\u201311.","journal-title":"Eur Heart J"},{"key":"1279_CR79","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.amjcard.2018.01.004","volume":"121","author":"FD Sigurdardottir","year":"2018","unstructured":"Sigurdardottir FD, Lyngbakken MN, Holmen OL, Dalen H, Hveem K, R\u00f8sj\u00f8 H, et al. Relative prognostic value of cardiac troponin I and C-reactive protein in the general population (from the Nord-Tr\u00f8ndelag Health [HUNT] Study). Am J Cardiol. 2018;121:949\u201355.","journal-title":"Am J Cardiol"},{"key":"1279_CR80","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.amjmed.2015.11.035","volume":"129","author":"T Baron","year":"2016","unstructured":"Baron T, Hambraeus K, Sundstr\u00f6m J, Erlinge D, Jernberg T, Lindahl B, et al. Impact on long-term mortality of presence of obstructive coronary artery disease and classification of myocardial infarction. Am J Med. 2016;129:398\u2013406.","journal-title":"Am J Med"},{"key":"1279_CR81","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.jacc.2017.07.774","volume":"70","author":"T Nestelberger","year":"2017","unstructured":"Nestelberger T, Boeddinghaus J, Badertscher P, Twerenbold R, Wildi K, Breitenb\u00fccher D, et al. Effect of definition on incidence and prognosis of type 2 myocardial infarction. J Am Coll Cardiol. 2017;70:1558\u201368.","journal-title":"J Am Coll Cardiol"},{"issue":"68","key":"1279_CR82","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1016\/j.jacc.2016.10.020","volume":"27","author":"I Ford","year":"2016","unstructured":"Ford I, Shah AS, Zhang R, McAllister DA, Strachan FE, Caslake M, et al. High-sensitivity cardiac troponin, statin therapy, and risk of coronary heart disease. J Am Coll Cardiol. 2016;27(68):2719\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR83","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1161\/CIRCULATIONAHA.114.014522","volume":"131","author":"BM Everett","year":"2015","unstructured":"Everett BM, Zeller T, Glynn RJ, Ridker PM, Blankenberg S. High-sensitivity cardiac troponin I and B-type natriuretic peptide as predictors of vascular events in primary prevention: impact of statin therapy. Circulation. 2015;131:1851\u201360.","journal-title":"Circulation."},{"issue":"61","key":"1279_CR84","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.jacc.2012.12.026","volume":"26","author":"T Omland","year":"2013","unstructured":"Omland T, Pfeffer MA, Solomon SD, de Lemos JA, R\u00f8sj\u00f8 H, \u0160altyt\u0117 Benth J, et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013;26(61):1240\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"1279_CR85","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","volume":"392","author":"ASV Shah","year":"2018","unstructured":"Shah ASV, Anand A, Strachan FE, Ferry AV, Lee KK, Chapman AR, et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018;392:919\u201328.","journal-title":"Lancet"},{"key":"1279_CR86","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1016\/S0140-6736(18)30832-8","volume":"391","author":"PJ Devereaux","year":"2018","unstructured":"Devereaux PJ, Duceppe E, Guyatt G, Tandon V, Rodseth R, Biccard BM, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet. 2018;391:2325\u201334.","journal-title":"Lancet"},{"key":"1279_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ahj.2018.09.016","volume":"208","author":"K Lambrakis","year":"2019","unstructured":"Lambrakis K, French JK, Scott IA, Briffa T, Brieger D, Farkouh ME, et al. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): a randomized trial design. Am Heart J. 2019;208:11\u201320.","journal-title":"Am Heart J"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01279-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-020-01279-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-020-01279-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T19:49:49Z","timestamp":1617047389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-020-01279-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,30]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["1279"],"URL":"https:\/\/doi.org\/10.1007\/s11886-020-01279-0","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,30]]},"assertion":[{"value":"30 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Michael C. Kontos and Jeremy S. Turlington declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"30"}}